2[1]Doong SL, Tsai CH, Schinazi RF, et al. Inhitibition of the replication of hepatitis B virus in vitro by 2', 3'-dideoxy-3 '-thiacytidine and related analogues. Proc Natl Acad Sci USA, 1991,88: 8495 ～8499
3[2]Tyrrell DLJ, Fischer K, Sayani K, et al. Treatment of chimpanzees and ducks with lamivudine, 2'-3'-dideoxy-3'-thiacytidine, results in a ropid suppression of hepadnaviral DNA in sera. Clin Invest Med, 1993,16( Suppl ) Abs. No. 487:B77
4[3]Yao F,Terrault N, Freisc C, et al. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort. Hepatology,2001,34:411 ～416
5[6]Hoofnagle JH, Lan D. New therapies for chronic hepatitis B. J Viral Hepat, 1997,4(Suppl 1):41 ～45
